Clinical characteristics and outcome of morbidly obese bariatric patients with concurrent hepatitis B viral infection

Wei Jei Lee, Weu Wang, Yi Chih Lee, Ming Te Huang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Bariatric surgery is the only effective and long-lasting treatment of morbidly obese patients. However, the safety and efficacy of bariatric surgery in patients with hepatitis B viral (HBV) infection is not clear. The aim of the present study is to investigate weather HBV infection influences clinic features and outcomes of bariatric surgery. Methods: The preoperative seropositivity of HBV surface antigen (HBsAg) using radioimmunoassay was determined in 592 patients (481 female, 111 male: mean age 30.5±8.1 years; mean body mass index [BMI] 43.1±6.0) who had undergone bariatric surgery (209 banding and 383 gastric bypass) for their morbid obesity in the past 5 years. All the clinical data were prospectively collected and stored. Results: The overall seroprevalence of HbsAg was 18.8%. Morbidly obese patients positive for HBV infection were associated with older age and higher diastolic blood pressure, but not with sex, BMI, liver enzyme, blood lipid, and glucose levels. Although minigastric bypass (MGB) had a better weight reduction than gastric banding, there was no difference in weight reduction between patients who were positive and negative for HBV infection. The weight loss curves and resolution of obesity-related comorbidities were similar between the two groups except the postoperative aspartate transaminase (AST) and alanine transaminase (ALT) were significantly higher in patients who were positive for HBV infection. During follow-up, two patients developed fulminating hepatitis after MGB with one mortality. Conclusion: Morbidly obese patients with the existence of HBV infection do not influence the outcome of bariatric surgery, but continuing monitor of the liver function is indicated.

Original languageEnglish
Pages (from-to)589-594
Number of pages6
JournalObesity Surgery
Volume18
Issue number5
DOIs
Publication statusPublished - May 2008

Fingerprint

Bariatrics
Virus Diseases
Hepatitis B
Bariatric Surgery
Weight Loss
Body Mass Index
Gastric Bypass
Morbid Obesity
Viral Antigens
Liver
Seroepidemiologic Studies
Weather
Hepatitis B Surface Antigens
Aspartate Aminotransferases
Alanine Transaminase
Hepatitis
Radioimmunoassay
Blood Glucose
Comorbidity
Stomach

Keywords

  • Bariatric surgery
  • HBV infection
  • Minigastric bypass
  • Morbid obesity

ASJC Scopus subject areas

  • Surgery

Cite this

Clinical characteristics and outcome of morbidly obese bariatric patients with concurrent hepatitis B viral infection. / Lee, Wei Jei; Wang, Weu; Lee, Yi Chih; Huang, Ming Te.

In: Obesity Surgery, Vol. 18, No. 5, 05.2008, p. 589-594.

Research output: Contribution to journalArticle

@article{6763a6120d254be2aa00d5347b20523f,
title = "Clinical characteristics and outcome of morbidly obese bariatric patients with concurrent hepatitis B viral infection",
abstract = "Background: Bariatric surgery is the only effective and long-lasting treatment of morbidly obese patients. However, the safety and efficacy of bariatric surgery in patients with hepatitis B viral (HBV) infection is not clear. The aim of the present study is to investigate weather HBV infection influences clinic features and outcomes of bariatric surgery. Methods: The preoperative seropositivity of HBV surface antigen (HBsAg) using radioimmunoassay was determined in 592 patients (481 female, 111 male: mean age 30.5±8.1 years; mean body mass index [BMI] 43.1±6.0) who had undergone bariatric surgery (209 banding and 383 gastric bypass) for their morbid obesity in the past 5 years. All the clinical data were prospectively collected and stored. Results: The overall seroprevalence of HbsAg was 18.8{\%}. Morbidly obese patients positive for HBV infection were associated with older age and higher diastolic blood pressure, but not with sex, BMI, liver enzyme, blood lipid, and glucose levels. Although minigastric bypass (MGB) had a better weight reduction than gastric banding, there was no difference in weight reduction between patients who were positive and negative for HBV infection. The weight loss curves and resolution of obesity-related comorbidities were similar between the two groups except the postoperative aspartate transaminase (AST) and alanine transaminase (ALT) were significantly higher in patients who were positive for HBV infection. During follow-up, two patients developed fulminating hepatitis after MGB with one mortality. Conclusion: Morbidly obese patients with the existence of HBV infection do not influence the outcome of bariatric surgery, but continuing monitor of the liver function is indicated.",
keywords = "Bariatric surgery, HBV infection, Minigastric bypass, Morbid obesity",
author = "Lee, {Wei Jei} and Weu Wang and Lee, {Yi Chih} and Huang, {Ming Te}",
year = "2008",
month = "5",
doi = "10.1007/s11695-007-9346-1",
language = "English",
volume = "18",
pages = "589--594",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York LLC",
number = "5",

}

TY - JOUR

T1 - Clinical characteristics and outcome of morbidly obese bariatric patients with concurrent hepatitis B viral infection

AU - Lee, Wei Jei

AU - Wang, Weu

AU - Lee, Yi Chih

AU - Huang, Ming Te

PY - 2008/5

Y1 - 2008/5

N2 - Background: Bariatric surgery is the only effective and long-lasting treatment of morbidly obese patients. However, the safety and efficacy of bariatric surgery in patients with hepatitis B viral (HBV) infection is not clear. The aim of the present study is to investigate weather HBV infection influences clinic features and outcomes of bariatric surgery. Methods: The preoperative seropositivity of HBV surface antigen (HBsAg) using radioimmunoassay was determined in 592 patients (481 female, 111 male: mean age 30.5±8.1 years; mean body mass index [BMI] 43.1±6.0) who had undergone bariatric surgery (209 banding and 383 gastric bypass) for their morbid obesity in the past 5 years. All the clinical data were prospectively collected and stored. Results: The overall seroprevalence of HbsAg was 18.8%. Morbidly obese patients positive for HBV infection were associated with older age and higher diastolic blood pressure, but not with sex, BMI, liver enzyme, blood lipid, and glucose levels. Although minigastric bypass (MGB) had a better weight reduction than gastric banding, there was no difference in weight reduction between patients who were positive and negative for HBV infection. The weight loss curves and resolution of obesity-related comorbidities were similar between the two groups except the postoperative aspartate transaminase (AST) and alanine transaminase (ALT) were significantly higher in patients who were positive for HBV infection. During follow-up, two patients developed fulminating hepatitis after MGB with one mortality. Conclusion: Morbidly obese patients with the existence of HBV infection do not influence the outcome of bariatric surgery, but continuing monitor of the liver function is indicated.

AB - Background: Bariatric surgery is the only effective and long-lasting treatment of morbidly obese patients. However, the safety and efficacy of bariatric surgery in patients with hepatitis B viral (HBV) infection is not clear. The aim of the present study is to investigate weather HBV infection influences clinic features and outcomes of bariatric surgery. Methods: The preoperative seropositivity of HBV surface antigen (HBsAg) using radioimmunoassay was determined in 592 patients (481 female, 111 male: mean age 30.5±8.1 years; mean body mass index [BMI] 43.1±6.0) who had undergone bariatric surgery (209 banding and 383 gastric bypass) for their morbid obesity in the past 5 years. All the clinical data were prospectively collected and stored. Results: The overall seroprevalence of HbsAg was 18.8%. Morbidly obese patients positive for HBV infection were associated with older age and higher diastolic blood pressure, but not with sex, BMI, liver enzyme, blood lipid, and glucose levels. Although minigastric bypass (MGB) had a better weight reduction than gastric banding, there was no difference in weight reduction between patients who were positive and negative for HBV infection. The weight loss curves and resolution of obesity-related comorbidities were similar between the two groups except the postoperative aspartate transaminase (AST) and alanine transaminase (ALT) were significantly higher in patients who were positive for HBV infection. During follow-up, two patients developed fulminating hepatitis after MGB with one mortality. Conclusion: Morbidly obese patients with the existence of HBV infection do not influence the outcome of bariatric surgery, but continuing monitor of the liver function is indicated.

KW - Bariatric surgery

KW - HBV infection

KW - Minigastric bypass

KW - Morbid obesity

UR - http://www.scopus.com/inward/record.url?scp=43049128792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049128792&partnerID=8YFLogxK

U2 - 10.1007/s11695-007-9346-1

DO - 10.1007/s11695-007-9346-1

M3 - Article

C2 - 18330660

AN - SCOPUS:43049128792

VL - 18

SP - 589

EP - 594

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 5

ER -